New AI tool reimagines infectious disease forecasting, outperforms existing state-of-the-art methods

Brain tumors remain among the most challenging conditions in modern medicine. Due to their complexity and location, many of them are difficult to access, even with the most advanced surgical and therapeutic approaches. Although significant progress has been made in radiotherapy, chemotherapy, and surgical techniques, certain tumors—especially those near critical brain structures—still present considerable risks.

Imagine treating chronic illness not with pills, but with soft, flexible electronic implants seamlessly integrated into the body. The materials for such implants already exist—they just needed a sweet touch.

The MRI shows a brain tumor in an inauspicious location, and a brain biopsy will entail high risks for a patient who had consulted doctors due to double vision. Situations such as this case prompted researchers at Charité—Universitätsmedizin Berlin to look for new diagnostic procedures. The result is an AI model.

An interdisciplinary research team from the Allergology and Veterinary Medicine Divisions at the Paul-Ehrlich-Institut (PEI) has developed a novel laboratory test that enables the determination of adjuvanted allergoids in finished medicinal products. Content analyses of finished medicinal products were not possible in the past due to the complex structure of this medicinal product group, which contains both adjuvants and allergoids (chemically modified allergens) and therefore had to be performed on an intermediary production step.

In much the same way people can "chat" with large language models like GPT-4, Stanford Health Care clinicians can now interact with a patient's medical records through an AI-backed software called ChatEHR.

A study led by Northeastern University professor Jonathan Peelle with researchers from across the globe has confirmed that people's ability to detect background sounds varies from person to person, and is influenced by the noise that came before the sounds.

Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology, in collaboration with partners from Germany, the U.K. and U.S., have developed and validated an autonomous artificial intelligence (AI) agent capable of supporting clinical decision-making in oncology.

Chronic inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, cause recurring diarrhea, fever, pain, and significant psychological distress. Despite major advances and modern medications, treatment remains challenging. Only a subset of patients responds to medication.

Hypertension or high blood pressure, which can lead to heart attack and stroke, the two top causes of death in the United States, is one of the most widespread chronic illnesses in America, afflicting nearly half of adults. In a recent Annenberg Public Policy Center (APPC) health survey, 35% of respondents report having been diagnosed with high blood pressure and two‐thirds of this group say they're somewhat or very worried about having high blood pressure.

During the first meeting of the Global Think-tank on Steatotic Liver Disease, supported by the Barcelona Institute for Global Health (ISGlobal) and held in the Palau Macaya of Barcelona on 5–6 June, more than 100 international experts issued a stark warning: millions of people will continue to go unseen by health care systems unless early detection and person-centered care for liver disease are prioritized without delay.

Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in medication abortions.

Alzheimer's disease, marked by memory loss, trouble concentrating and thinking, and changes in personality and behavior, devastates patients, their families and loved ones. With new treatments available for people with early signs of Alzheimer's disease, there is a growing need for accessible and cost-effective tests to diagnose Alzheimer's disease sooner.

Body mass index (BMI) and physical activity are associated with the risk for subsequent neoplasms among childhood cancer survivors, according to a study published online June 5 in JAMA Oncology.

Economic disadvantage leaves a biological imprint on children which could last throughout their lifetime, reducing their quality and length of life. These are the findings of a study of more than 1,000 European children led by researchers at Imperial College London. The research finds evidence that the impacts of socioeconomic status can be seen in the blood cells of children, with those from less privileged backgrounds having shorter telomeres—an established biomarker for aging.

A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), enabling earlier and more accurate detection of this aggressive disease, according a paper published in The Journal of Nuclear Medicine titled "Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer."

A cheap over-the-counter supplement could hold the key to preventing heart failure in people with Type 2 diabetes, according to research presented Tuesday at the British Cardiovascular Society conference in Manchester.

To enhance existing strategies for controlling the Aedes aegypti mosquito, geoinformation scientist Dr. Steffen Knoblauch has created a high-resolution environmental suitability map for Rio de Janeiro (Brazil) that can help identify areas most conducive to breeding.

Social engagement is a vital component of psychological and physical well-being linked to better health and a longer life, yet many older adults struggle to maintain relationships that support these outcomes.